Clinical case of meningoencephalitis of Epstein-Barr viral etiology in an immunocompetent patient




Epstein–Barr virus, encephalitis, meningoencephalitis, magnetic resonance imaging, ticoids


The article describes a rare clinical case of meningoencephalitis of Epstein-Barr viral (EBV) etiology in an immunocompetent patient. The purpose of the work was to acquaint practitioners with the problems of diagnosis and treatment of EBV-neuroinfection, features of the course and management of EBV-meningoencephalitis. The woman, 46 years old, was admitted to the intensive care unit with a diagnosis of mushroom poisoning. Based on clinical-laboratory-instrumental examinations the diagnosis of EBV-meningoencephalitis was made. EBV DNA was detected in the cerebrospinal fluid by polymerase chain reaction (PCR) and magnetic resonance imaging (MRI) of the brain showed focal changes in the left temporal-insular region with signs of leptomeningitis. Taking into account the specifics of this case, the authors of the article came to the following conclusions: EBV-meningoencephalitis can occur in people with normal immune status under conditions of psychological and physical stress; delayed diagnosis of meningoencephalitis at the onset of the disease in this case is associated with the prevalence of clinical manifestations of general brain syndrome, mistakenly regarded as symptoms of intoxication and dyspepsia due to food poisoning; meningoencephalitis of EBV-etiology is ac­companied by signs of convulsive, atactic, cognitive and mental syndromes; temporal-insular localization of focal brain changes may be characteristic for EBV-meningoencephalitis; treatment with acyclovir and glucocorticoids may have be­nefits; complicated vascular anamnesis, bed rest and glucocorticoid therapy predict an increased risk of venous thrombosis, which in this patient was realized as acute sural phlebothrombosis; according to MRI the resolution of leptomeningitis and focal brain changes with gliosis formation occurred 3 months after manifestation of the disease; the risk of the following neurological pathologies due to specific localization of gliosis should be considered and requires medical control.


Venkatesan A, Michael BD, Probasco JC, Geocadin RG, Solomon T. Acute encephalitis in immuno-competent adults. Lancet. 2019;393:702-16. doi:

Andleeb S, Yasir Bari M, Gill I, Urooj S, Nausheen S. Incidence of Encephalitis in the Intensive Care Unit, a Tertiary Care Hospital, Pakistan: A 5-Year Retrospective Study. Turk J Anaesthesiol Reanim. 2020;48(4):288-93. doi:

Payal B Patel. BMJ Best Practice. Encephalitis. London: BMJ Publishing Group Ltd; 2023 [last updated: 2022 Aug 16]. 130 p. Available from:

Huang L, Zhang X, Fang X. Case report: Epstein–Barr virus encephalitis complicated with brain stem hemorrhage in an immune-competent adult. Frontiers in immunology. 2021;12:618830. doi:

Rudenko AO, Muravska LV, Diachenko PA, Parkhomets BA, Klius VJ. [Clinical peculiarities of nervous system defeats in patients with EBV monoinfection and in assotiation with other herpesvirus in their reactivation and persistence]. Actual Infectology. 2017;5(6):260-4. Ukrainian. doi:

Maltsev DV. [Herpesvirus neuroinfections in cli-nical cases]. Kyiv: Interservice; 2021. 224 p. Ukrainian.

Song DL, Wang JS, Chen LL, Wang Z. Chronic active Epstein-Barr virus infection treated with PEG-aspargase: A case report. World J Clin Cases. 2021;16;9(26):7845-9. doi:

Cohen JI. Optimal treatment for chronic active Epstein-Barr virus disease. Pediatr Transplant. 2009;13(4):393-6. doi:

Zarlasht F, et al. Encephalitis treatment–a case report with long-term follow-up of EBV PCR in cere-brospinal fluid. Int J of Gen Med. 2017;10:371-3. doi:

Tsuruyama Y, Mori N, Yoshida S, Hayashi T. Ep-stein-Barr virus-related encephalitis in a young woman: A case report. Journal of Infection and Chemotherapy. 2020;26(7):741-4. doi:



How to Cite

Popovych O, Moroz L, Chabanov F, Androsova O, Kulias S, Chichirelo-Konstantynovych K, Plotytsia L. Clinical case of meningoencephalitis of Epstein-Barr viral etiology in an immunocompetent patient. Med. perspekt. [Internet]. 2023Sep.29 [cited 2024Mar.3];28(3):226-33. Available from: